Pantoprazole (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Pantoprazole" in English language version.

refsWebsite

Global rank English rank

33nih.gov

4^th place

18doi.org

2^nd place

5fda.gov

447^th place

338^th place

4semanticscholar.org

11^th place

8^th place

3drugs.com

399^th place

333^rd place

2clincalc.com

3,912^th place

2,496^th place

2web.archive.org

1^st place

2fiercepharma.com

low place

8,921^st place

2nytimes.com

7^th place

1medicines.org.uk

3,823^rd place

2,387^th place

1ubc.ca

1,997^th place

1,295^th place

1books.google.com

3^rd place

1aihw.gov.au

low place

1chron.com

599^th place

369^th place

1archive.org

6^th place

1law360.com

6,282^nd place

3,410^th place

1wsj.com

79^th place

65^th place

1marketwatch.com

1,303^rd place

808^th place

aihw.gov.au

"Medicines in the health system". Australian Institute of Health and Welfare. 2 July 2024. Retrieved 30 September 2024.

archive.org

Senn-Bilfinger J, Sturm E (2006). "6. The Development of a New Proton-Pump Inhibitor: The Case History of Pantoprazole". In Fischer J, Ganellin CR (eds.). Analogue-based drug discovery. Weinheim: Wiley-VCH. pp. 115–136. ISBN 9783527608003.

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 130. ISBN 9783527607495.

chron.com

blog.chron.com

Ackerman T (10 July 2013). "Acid reflux drugs may lead to heart disease, says Houston study". Houston Chronicle.

clincalc.com

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Pantoprazole Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.

doi.org

Richardson P, Hawkey CJ, Stack WA (September 1998). "Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders". Drugs. 56 (3): 307–335. doi:10.2165/00003495-199856030-00002. PMID 9777309. S2CID 46962618.
Dammann HG, Fölsch UR, Hahn EG, von Kleist DH, Klör HU, Kirchner T, et al. (March 2000). "Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration". Helicobacter. 5 (1): 41–51. doi:10.1046/j.1523-5378.2000.00006.x. PMID 10672051. S2CID 32184484.{{cite journal}}: CS1 maint: overridden setting (link)
Strand DS, Kim D, Peura DA (January 2017). "25 Years of Proton Pump Inhibitors: A Comprehensive Review". Gut and Liver. 11 (1): 27–37. doi:10.5009/gnl15502. PMC 5221858. PMID 27840364.
Herzig SJ, Doughty C, Lahoti S, Marchina S, Sanan N, Feng W, et al. (November 2014). "Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia". Annals of Neurology. 76 (5): 712–718. doi:10.1002/ana.24262. PMC 4214881. PMID 25164323.
Ricketson J, Kimel G, Spence J, Weir R (March 2009). "Acute allergic interstitial nephritis after use of pantoprazole". CMAJ. 180 (5): 535–538. doi:10.1503/cmaj.080456. PMC 2645468. PMID 19255077.
Seifert R (2019). "Drugs for Treatment of Gastrointestinal Diseases". In Seifert R (ed.). Basic Knowledge of Pharmacology (in German). Cham: Springer International Publishing. pp. 167–180. doi:10.1007/978-3-030-18899-3_13. ISBN 978-3-030-18899-3. S2CID 200109770.
Wolfe MM, Sachs G (February 2000). "Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome". Gastroenterology. 118 (2 Suppl 1): S9-31. doi:10.1016/s0016-5085(00)70004-7. PMID 10868896.
Meyer UA (October 1996). "Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs". European Journal of Gastroenterology & Hepatology. 8 (Suppl 1): S21 – S25. doi:10.1097/00042737-199610001-00005. PMID 8930576. S2CID 24171788.
Sachs G, Shin JM, Hunt R (December 2010). "Novel approaches to inhibition of gastric acid secretion". Current Gastroenterology Reports. 12 (6): 437–447. doi:10.1007/s11894-010-0149-5. PMC 2974194. PMID 20924727.
Mathews S, Reid A, Tian C, Cai Q (2010). "An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease". Clinical and Experimental Gastroenterology. 3: 11–16. doi:10.2147/ceg.s6355. PMC 3108659. PMID 21694841.
Curtiss FR (April 2008). "Perspectives on the "generic cliff"--pushing and falling". Journal of Managed Care Pharmacy. 14 (3): 318–321. doi:10.18553/jmcp.2008.14.3.318. PMC 10438035. PMID 18439056.
Smith JS, Kosusnik AR, Mochel JP (2020). "A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants". Frontiers in Veterinary Science. 7: 97. doi:10.3389/fvets.2020.00097. PMC 7089877. PMID 32258063.
Olivarez JD, Kreuder AJ, Tatarniuk DM, Wulf LW, Dembek KA, Mochel JP, et al. (2020). "Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration". Frontiers in Veterinary Science. 7: 580735. doi:10.3389/fvets.2020.580735. PMC 7728716. PMID 33330703.
Ryan CA, Sanchez LC, Giguère S, Vickroy T (July 2005). "Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals". Equine Veterinary Journal. 37 (4): 336–341. doi:10.2746/0425164054529427. PMID 16028623.
Smith GW, Davis JL, Smith SM, Gerard MP, Campbell NB, Foster DM (July 2010). "Efficacy and pharmacokinetics of pantoprazole in alpacas". Journal of Veterinary Internal Medicine. 24 (4): 949–955. doi:10.1111/j.1939-1676.2010.0508.x. PMID 20384953.
Smith JS, Mochel JP, Soto-Gonzalez WM, Rahn RR, Fayne BN, Escher OG, et al. (2021). "Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report". Frontiers in Veterinary Science. 8: 744813. doi:10.3389/fvets.2021.744813. PMC 8492921. PMID 34631865.{{cite journal}}: CS1 maint: overridden setting (link)
Smith JS, Kosusnik AR, Mochel JP (2020). "A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants". Frontiers in Veterinary Science. 7: 97. doi:10.3389/fvets.2020.00097. PMC 7089877. PMID 32258063.
Olivarez JD, Mulon PY, Ebner LS, Cremerius H, Cantrell C, Rahn R, et al. (30 January 2023). "Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves". Frontiers in Veterinary Science. 9: 1101461. doi:10.3389/fvets.2022.1101461. PMC 9923100. PMID 36794231.{{cite journal}}: CS1 maint: overridden setting (link)

drugs.com

"Pantoprazole international brand names". Drugs.com. Retrieved 15 March 2017.
"Pantoprazole Use During Pregnancy". Drugs.com. 26 June 2018. Retrieved 20 February 2020.
"Pantoprazole Sodium Monograph for Professionals - Drugs.com". Drugs.com. American Society of Health-System Pharmacists. Retrieved 28 October 2018.

fda.gov

accessdata.fda.gov

"Pantoprazole: FDA-Approved Drugs". U.S. Food and Drug Administration. Retrieved 15 August 2020.
"Drug Approval Package: Protonix (Pantoprazole Sodium) NDA 20987". Food and Drug Administration. 24 December 1999. Retrieved 20 February 2020.

fda.gov

Center for Drug Evaluation and Research. "Postmarket Drug Safety Information for Patients and Providers - FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors". U.S. Food and Drug Administration (FDA). Archived from the original on 20 January 2017. Retrieved 3 November 2015.
Center for Drug Evaluation and Research. "Drug Safety and Availability - FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs)". U.S. Food and Drug Administration (FDA). Retrieved 3 November 2015.

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

fiercepharma.com

"Protonix - Big Patent Expirations of 2010". FiercePharma. Retrieved 15 March 2017.
Helfand C (12 June 2013). "Teva loses $2B gamble on generic of Pfizer's Protonix". FiercePharma.

law360.com

Daly EM (20 May 2008). "Wyeth, Nycomed Take Aim At Sandoz Over Protonix". Law360.

marketwatch.com

Davis A (23 January 2009). "Pfizer in talks to acquire Wyeth in $60 billion deal: WSJ". MarketWatch. Retrieved 11 August 2012.

medicines.org.uk

"Pantoprazole 20mg gastro-resistant tablets - Summary of Product Characteristics (SmPC)". (emc). 25 November 2019. Retrieved 20 February 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Bernshteyn MA, Masood U (2022). "Pantoprazole". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29763120. Retrieved 27 April 2022.
Richardson P, Hawkey CJ, Stack WA (September 1998). "Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders". Drugs. 56 (3): 307–335. doi:10.2165/00003495-199856030-00002. PMID 9777309. S2CID 46962618.
Dammann HG, Fölsch UR, Hahn EG, von Kleist DH, Klör HU, Kirchner T, et al. (March 2000). "Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration". Helicobacter. 5 (1): 41–51. doi:10.1046/j.1523-5378.2000.00006.x. PMID 10672051. S2CID 32184484.{{cite journal}}: CS1 maint: overridden setting (link)
Strand DS, Kim D, Peura DA (January 2017). "25 Years of Proton Pump Inhibitors: A Comprehensive Review". Gut and Liver. 11 (1): 27–37. doi:10.5009/gnl15502. PMC 5221858. PMID 27840364.
Herzig SJ, Doughty C, Lahoti S, Marchina S, Sanan N, Feng W, et al. (November 2014). "Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia". Annals of Neurology. 76 (5): 712–718. doi:10.1002/ana.24262. PMC 4214881. PMID 25164323.
Ricketson J, Kimel G, Spence J, Weir R (March 2009). "Acute allergic interstitial nephritis after use of pantoprazole". CMAJ. 180 (5): 535–538. doi:10.1503/cmaj.080456. PMC 2645468. PMID 19255077.
Ahmed A, Clarke JO (2022). "Proton Pump Inhibitors (PPI)". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32491317. Retrieved 29 April 2022.
Wolfe MM, Sachs G (February 2000). "Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome". Gastroenterology. 118 (2 Suppl 1): S9-31. doi:10.1016/s0016-5085(00)70004-7. PMID 10868896.
Meyer UA (October 1996). "Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs". European Journal of Gastroenterology & Hepatology. 8 (Suppl 1): S21 – S25. doi:10.1097/00042737-199610001-00005. PMID 8930576. S2CID 24171788.
Sachs G, Shin JM, Hunt R (December 2010). "Novel approaches to inhibition of gastric acid secretion". Current Gastroenterology Reports. 12 (6): 437–447. doi:10.1007/s11894-010-0149-5. PMC 2974194. PMID 20924727.
Mathews S, Reid A, Tian C, Cai Q (2010). "An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease". Clinical and Experimental Gastroenterology. 3: 11–16. doi:10.2147/ceg.s6355. PMC 3108659. PMID 21694841.
Curtiss FR (April 2008). "Perspectives on the "generic cliff"--pushing and falling". Journal of Managed Care Pharmacy. 14 (3): 318–321. doi:10.18553/jmcp.2008.14.3.318. PMC 10438035. PMID 18439056.
Smith JS, Kosusnik AR, Mochel JP (2020). "A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants". Frontiers in Veterinary Science. 7: 97. doi:10.3389/fvets.2020.00097. PMC 7089877. PMID 32258063.
Olivarez JD, Kreuder AJ, Tatarniuk DM, Wulf LW, Dembek KA, Mochel JP, et al. (2020). "Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration". Frontiers in Veterinary Science. 7: 580735. doi:10.3389/fvets.2020.580735. PMC 7728716. PMID 33330703.
Ryan CA, Sanchez LC, Giguère S, Vickroy T (July 2005). "Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals". Equine Veterinary Journal. 37 (4): 336–341. doi:10.2746/0425164054529427. PMID 16028623.
Smith GW, Davis JL, Smith SM, Gerard MP, Campbell NB, Foster DM (July 2010). "Efficacy and pharmacokinetics of pantoprazole in alpacas". Journal of Veterinary Internal Medicine. 24 (4): 949–955. doi:10.1111/j.1939-1676.2010.0508.x. PMID 20384953.
Smith JS, Mochel JP, Soto-Gonzalez WM, Rahn RR, Fayne BN, Escher OG, et al. (2021). "Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report". Frontiers in Veterinary Science. 8: 744813. doi:10.3389/fvets.2021.744813. PMC 8492921. PMID 34631865.{{cite journal}}: CS1 maint: overridden setting (link)
Smith JS, Kosusnik AR, Mochel JP (2020). "A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants". Frontiers in Veterinary Science. 7: 97. doi:10.3389/fvets.2020.00097. PMC 7089877. PMID 32258063.
Olivarez JD, Mulon PY, Ebner LS, Cremerius H, Cantrell C, Rahn R, et al. (30 January 2023). "Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves". Frontiers in Veterinary Science. 9: 1101461. doi:10.3389/fvets.2022.1101461. PMC 9923100. PMID 36794231.{{cite journal}}: CS1 maint: overridden setting (link)

ncbi.nlm.nih.gov

Bernshteyn MA, Masood U (2022). "Pantoprazole". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 29763120. Retrieved 27 April 2022.
Strand DS, Kim D, Peura DA (January 2017). "25 Years of Proton Pump Inhibitors: A Comprehensive Review". Gut and Liver. 11 (1): 27–37. doi:10.5009/gnl15502. PMC 5221858. PMID 27840364.
Herzig SJ, Doughty C, Lahoti S, Marchina S, Sanan N, Feng W, et al. (November 2014). "Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia". Annals of Neurology. 76 (5): 712–718. doi:10.1002/ana.24262. PMC 4214881. PMID 25164323.
Ricketson J, Kimel G, Spence J, Weir R (March 2009). "Acute allergic interstitial nephritis after use of pantoprazole". CMAJ. 180 (5): 535–538. doi:10.1503/cmaj.080456. PMC 2645468. PMID 19255077.
Ahmed A, Clarke JO (2022). "Proton Pump Inhibitors (PPI)". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32491317. Retrieved 29 April 2022.
Sachs G, Shin JM, Hunt R (December 2010). "Novel approaches to inhibition of gastric acid secretion". Current Gastroenterology Reports. 12 (6): 437–447. doi:10.1007/s11894-010-0149-5. PMC 2974194. PMID 20924727.
Mathews S, Reid A, Tian C, Cai Q (2010). "An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease". Clinical and Experimental Gastroenterology. 3: 11–16. doi:10.2147/ceg.s6355. PMC 3108659. PMID 21694841.
Curtiss FR (April 2008). "Perspectives on the "generic cliff"--pushing and falling". Journal of Managed Care Pharmacy. 14 (3): 318–321. doi:10.18553/jmcp.2008.14.3.318. PMC 10438035. PMID 18439056.
Smith JS, Kosusnik AR, Mochel JP (2020). "A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants". Frontiers in Veterinary Science. 7: 97. doi:10.3389/fvets.2020.00097. PMC 7089877. PMID 32258063.
Olivarez JD, Kreuder AJ, Tatarniuk DM, Wulf LW, Dembek KA, Mochel JP, et al. (2020). "Pharmacokinetics and Tissue Levels of Pantoprazole in Neonatal Calves After Intravenous Administration". Frontiers in Veterinary Science. 7: 580735. doi:10.3389/fvets.2020.580735. PMC 7728716. PMID 33330703.
Smith JS, Mochel JP, Soto-Gonzalez WM, Rahn RR, Fayne BN, Escher OG, et al. (2021). "Pharmacokinetics of Pantoprazole and Pantoprazole Sulfone in Goats After Intravenous Administration: A Preliminary Report". Frontiers in Veterinary Science. 8: 744813. doi:10.3389/fvets.2021.744813. PMC 8492921. PMID 34631865.{{cite journal}}: CS1 maint: overridden setting (link)
Smith JS, Kosusnik AR, Mochel JP (2020). "A Retrospective Clinical Investigation of the Safety and Adverse Effects of Pantoprazole in Hospitalized Ruminants". Frontiers in Veterinary Science. 7: 97. doi:10.3389/fvets.2020.00097. PMC 7089877. PMID 32258063.
Olivarez JD, Mulon PY, Ebner LS, Cremerius H, Cantrell C, Rahn R, et al. (30 January 2023). "Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves". Frontiers in Veterinary Science. 9: 1101461. doi:10.3389/fvets.2022.1101461. PMC 9923100. PMID 36794231.{{cite journal}}: CS1 maint: overridden setting (link)

dailymed.nlm.nih.gov

"Protonix delayed-release- pantoprazole sodium tablet, delayed release Protonix delayed-release- pantoprazole sodium granule, delayed release". DailyMed. 2 May 2019. Retrieved 20 February 2020.

nytimes.com

dealbook.nytimes.com

"Takeda to Buy Nycomed for $13.7 Billion". DealBook. 19 May 2011.

nytimes.com

Saul S (7 September 2007). "Wyeth Faces Generic Rival to a Heartburn Drug". The New York Times.

semanticscholar.org

api.semanticscholar.org

Richardson P, Hawkey CJ, Stack WA (September 1998). "Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders". Drugs. 56 (3): 307–335. doi:10.2165/00003495-199856030-00002. PMID 9777309. S2CID 46962618.
Dammann HG, Fölsch UR, Hahn EG, von Kleist DH, Klör HU, Kirchner T, et al. (March 2000). "Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration". Helicobacter. 5 (1): 41–51. doi:10.1046/j.1523-5378.2000.00006.x. PMID 10672051. S2CID 32184484.{{cite journal}}: CS1 maint: overridden setting (link)
Seifert R (2019). "Drugs for Treatment of Gastrointestinal Diseases". In Seifert R (ed.). Basic Knowledge of Pharmacology (in German). Cham: Springer International Publishing. pp. 167–180. doi:10.1007/978-3-030-18899-3_13. ISBN 978-3-030-18899-3. S2CID 200109770.
Meyer UA (October 1996). "Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs". European Journal of Gastroenterology & Hepatology. 8 (Suppl 1): S21 – S25. doi:10.1097/00042737-199610001-00005. PMID 8930576. S2CID 24171788.

ubc.ca

ti.ubc.ca

"[99] Comparative effectiveness of proton pump inhibitors". Therapeutics Initiative. 28 June 2016. Retrieved 14 July 2016.

web.archive.org

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
Center for Drug Evaluation and Research. "Postmarket Drug Safety Information for Patients and Providers - FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors". U.S. Food and Drug Administration (FDA). Archived from the original on 20 January 2017. Retrieved 3 November 2015.

wsj.com

blogs.wsj.com

Goldstein J (30 January 2008). "Generic Protonix and Wyeth as Takeover Bait". WSJ.